Warts, Nongenital: Multimedia

References

1. Cohen PR, Hebert AA, Adler-Storthz K. Focal epithelial hyperplasia: Heck disease. Pediatr Dermatol. Sep 1993;10(3):245-51. [Medline].

2. Guadara J, Sergi A, Labruna V, Welch M, Gazivoda PL. Transformation of plantar verruca into squamous cell carcinoma. J Foot Surg. Nov-Dec 1992;31(6):611-4. [Medline].

3. Kolker AR, Wolfort FG, Upton J, Tahan SR, Hein KD, Zewert TE. Plantar verrucous carcinoma following transmetatarsal amputation and renal transplantation. Ann Plast Surg. May 1998;40(5):515-9. [Medline].

4. Noel JC, Detremmerie O, Peny MO, et al. Transformation of common warts into squamous cell carcinoma on sun-exposed areas in an immunosuppressed patient. Dermatology. 1994;189(3):308-11. [Medline].

5. Mallory SB, Baugh LS, Parker RK. Warts in blacks versus whites. Pediatr Dermatol. Mar 1991;8(1):91. [Medline].

6. Silverberg NB. Human papillomavirus infections in children. Curr Opin Pediatr. Aug 2004;16(4):402-9. [Medline].

7. Holland TT, Weber CB, James WD. Tender periungual nodules. Myrmecia (deep palmoplantar warts). Arch Dermatol. Jan 1992;128(1):105-6, 108-9. [Medline].

8. Bellew SG, Quartarolo N, Janniger CK. Childhood warts: an update. Cutis. Jun 2004;73(6):379-84. [Medline].

9. Goldfarb MT, Gupta AK, Gupta MA, Sawchuk WS. Office therapy for human papillomavirus infection in nongenital sites. Dermatol Clin. Apr 1991;9(2):287-96. [Medline].

10. Mizuki D, Kaneko T, Hanada K. Successful treatment of topical photodynamic therapy using 5-aminolevulinic acid for plane warts. Br J Dermatol. Nov 2003;149(5):1087-8. [Medline].

11. Perrett CM, Harwood C, Brown V. Topical 5% imiquimod treatment for refractory cutaneous warts. J Am Acad Dermatol. 2004;50(3):P41.

12. Roark TR, Pandya AG. Combination therapy of resistant warts in a patient with AIDS. Dermatol Surg. Dec 1998;24(12):1387-9. [Medline].

13. Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. May 2005;141(5):589-94. [Medline].

14. James MP, Collier PM, Aherne W, et al. Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts. J Am Acad Dermatol. Jun 1993;28(6):933-7. [Medline].

15. Munn SE, Higgins E, Marshall M, Clement M. A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol. Dec 1996;135(6):969-71. [Medline].

16. Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol. Jun 1996;34(6):1005-7. [Medline].

17. Kottke MD, Parker SR. Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. J Am Acad Dermatol. Sep 2006;55(3):533-6. [Medline].

18. Zabawski EJ Jr, Sands B, Goetz D, Naylor M, Cockerell CJ. Treatment of verruca vulgaris with topical cidofovir. JAMA. Oct 15 1997;278(15):1236. [Medline].

19. Focht DR 3rd, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. Oct 2002;156(10):971-4. [Medline].

20. [Best Evidence] Wenner R, Askari SK, Cham PM, Kedrowski DA, Liu A, Warshaw EM. Duct tape for the treatment of common warts in adults: a double-blind randomized controlled trial. Arch Dermatol. Mar 2007;143(3):309-13. [Medline].

21. Ewin DM. Hypnotherapy for warts (verruca vulgaris): 41 consecutive cases with 33 cures. Am J Clin Hypn. Jul 1992;35(1):1-10. [Medline].

22. Silverberg NB. Garlic cloves for verruca vulgaris. Pediatr Dermatol. Mar-Apr 2002;19(2):183. [Medline].

23. Millar BC, Moore JE. Successful topical treatment of hand warts in a paediatric patient with tea tree oil (Melaleuca alternifolia). Complement Ther Clin Pract. Nov 2008;14(4):225-7. [Medline].

24. Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol. Mar 1995;132(3):433-6. [Medline].

25. Berth-Jones J, Hutchinson PE. Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol. Sep 1992;127(3):262-5. [Medline].

26. Gloster HM Jr, Roenigk RK. Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol. Mar 1995;32(3):436-41. [Medline].

27. Sloan K, Haberman H, Lynde CW. Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis. J Cutan Med Surg. Jan 1998;2(3):142-5. [Medline].

28. Hughes PS, Hughes AP. Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts. J Am Acad Dermatol. Mar 1998;38(3):426-8. [Medline].

29. Rivera A, Tyring SK. Therapy of cutaneous human Papillomavirus infections. Dermatol Ther. 2004;17(6):441-8. [Medline].

30. Androphy EJ. Human papillomavirus. Current concepts. Arch Dermatol. May 1989;125(5):683-5. [Medline].

31. Baker GE, Tyring SK. Therapeutic approaches to papillomavirus infections. Dermatol Clin. Apr 1997;15(2):331-40. [Medline].

32. Benton EC. Therapy of cutaneous warts. Clin Dermatol. May-Jun 1997;15(3):449-55. [Medline].

33. Bouwes Bavinck JN, Berkhout RJ. HPV infections and immunosuppression. Clin Dermatol. May-Jun 1997;15(3):427-37. [Medline].

34. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol. Apr 1990;22(4):547-66. [Medline].

35. Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for warts: human papillomavirus. Committee on Guidelines of Care. J Am Acad Dermatol. Jan 1995;32(1):98-103. [Medline].

36. Jablonska S, Majewski S, Obalek S, Orth G. Cutaneous warts. Clin Dermatol. May-Jun 1997;15(3):309-19. [Medline].

37. Kilkenny M, Marks R. The descriptive epidemiology of warts in the community. Australas J Dermatol. May 1996;37(2):80-6. [Medline].

38. Matsukura T, Iwasaki T, Kawashima M. Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes. Virology. Sep 1992;190(1):561-4. [Medline].

39. Melton JL, Rasmussen JE. Clinical manifestations of human papillomavirus infection in nongenital sites. Dermatol Clin. Apr 1991;9(2):219-33. [Medline].

40. Schachner L, Ling NS, Press S. A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol. Oct 1983;1(2):157-64. [Medline].

41. Siegfried EC. Warts on children: an approach to therapy. Pediatr Ann. Feb 1996;25(2):79-90. [Medline].

42. Yanagihara M, Sumi A, Mori S. Papillomavirus antigen in the epidermoid cyst of the sole. Immunohistochemical and ultrastructural study. J Cutan Pathol. Dec 1989;16(6):375-81. [Medline].

43. Young R, Jolley D, Marks R. Comparison of the use of standardized diagnostic criteria and intuitive clinical diagnosis in the diagnosis of common viral warts (verrucae vulgaris). Arch Dermatol. Dec 1998;134(12):1586-9. [Medline].

Further Reading

Keywords

nongenital warts, human papilloma viruses, HPV, common warts, verruca vulgaris, flat warts, palmoplantar warts, myrmecia, focal epithelial hyperplasia, Heck disease, plantar cysts, epidermodysplasia verruciformis, verrucous carcinoma, filiform warts, Koebner phenomenon, butcher's warts, hyperproliferative cauliflowerlike lesions, mosaic wart, cystic warts, plantar epidermoid cysts, epidermal inclusion cyst

Contributor Information and Disclosures

Author

Philip D Shenefelt, MD, MS, Associate Professor, Department of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine; Past Chief, Section of Dermatology, James A Haley Veteran Affairs Medical Center
Philip D Shenefelt, MD, MS is a member of the following medical societies: American Academy of Dermatology, American College of Physician Executives, American Contact Dermatitis Society, American Medical Association, American Society of Clinical Hypnosis, Florida Medical Association, Noah Worcester Dermatological Society, and Society for Clinical and Experimental Hypnosis
Disclosure: Nothing to disclose.

Medical Editor

Mark W Cobb, MD, Consulting Staff, WNC Dermatological Associates
Mark W Cobb, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and American Society of Dermatopathology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory
Lester F Libow, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other